Michael Scolaro

Michael Scolaro

Oct 20, 2017

Group 6 Copy 111
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Do human activities increase antibiotic-resistant disease in Chilean penguins?

    Penguins are suffering population declines due to a variety of human causes, including disease. One indicator...

    A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

    The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

    How do chemical exposures trigger autoimmune diseases?

    The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

    Backer Badge Funded